Revision as of 20:05, 20 September 2011 editBogBot (talk | contribs)Bots53,132 edits populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot← Previous edit | Revision as of 20:16, 20 September 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to watched fields - added verified revid - updated 'ChemSpiderID_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[WikipedNext edit → | ||
Line 1: | Line 1: | ||
{{Drugbox | {{Drugbox | ||
| Watchedfields = changed | |||
| verifiedrevid = |
| verifiedrevid = 449576653 | ||
| IUPAC_name = 2-(2-oxopyrrolidin-1-yl)-N'-acetohydrazide | | IUPAC_name = 2-(2-oxopyrrolidin-1-yl)-N'-acetohydrazide | ||
| image = Dupracetam_structure.png | | image = Dupracetam_structure.png |
Revision as of 20:16, 20 September 2011
Pharmaceutical compoundClinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.056.279 |
Chemical and physical data | |
Formula | C12H18N4O4 |
Molar mass | 282.296 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
(verify) |
Dupracetam is a nootropic drug from the racetam family.
See also
References
- Dell HD, Jacobi H, Kamp R, Kurz J, Wünsche C (1981). "". Archiv Der Pharmazie (in German). 314 (8): 697–702. PMID 7294979.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - Hall ED, Von Voigtlander PF (1987). "Facilitatory effects of piracetam on excitability of motor nerve terminals and neuromuscular transmission". Neuropharmacology. 26 (11): 1573–9. doi:10.1016/0028-3908(87)90003-7. PMID 2829047.
{{cite journal}}
: Unknown parameter|month=
ignored (help)
Racetams | |
---|---|
Racetams |
|
Phenylpiracetams |
|
Racetam-like |
|
This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |